Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient
- PMID: 17622327
- PMCID: PMC1906681
- DOI: 10.2119/2006–00069.Ihalainen
Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient
Abstract
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a vascular dementing disease caused by mutations in the NOTCH3 gene, most which are missense mutations leading to an uneven number of cysteine residues in epidermal growth factor-like repeats in the extracellular domain of Notch3 receptor (N3ECD). CADASIL is characterized by degeneration of vascular smooth muscle cells (VSMC) and accumulation of N3ECD on the VSMCs of small and middle-sized arteries. Recent studies have demonstrated that impairment of Notch3 signaling is not the primary cause of the disease. In the present study we used proteomic analysis to characterize the protein expression pattern of a unique material of genetically genuine cultured human CADASIL VSMCs. We identified 11 differentially expressed proteins, which are involved in protein degradation and folding, contraction of VSMCs, and cellular stress. Our findings indicate that misfolding of Notch3 may cause endoplasmic reticulum stress and activation of unfolded protein response, leading to increased reactive oxygen species and inhibition of cell proliferation. In addition, upregulation of contractile proteins suggests an alteration in the signaling system of VSMC contraction. The accumulation of N3ECD on the cell surface possibly upregulates the angiotensin II regulatory feedback loop and thereby enhances the readiness of the cells to respond to angiotensin II stimulation.
Figures


Similar articles
-
CADASIL mutations and shRNA silencing of NOTCH3 affect actin organization in cultured vascular smooth muscle cells.J Cereb Blood Flow Metab. 2012 Dec;32(12):2171-80. doi: 10.1038/jcbfm.2012.123. Epub 2012 Sep 5. J Cereb Blood Flow Metab. 2012. PMID: 22948298 Free PMC article. Clinical Trial.
-
Nuclear abnormalities in vascular myocytes in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).Neuropathology. 2018 Dec;38(6):601-608. doi: 10.1111/neup.12519. Epub 2018 Nov 6. Neuropathology. 2018. PMID: 30402942
-
Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells.Eur J Cell Biol. 2018 Nov;97(8):557-567. doi: 10.1016/j.ejcb.2018.10.001. Epub 2018 Oct 22. Eur J Cell Biol. 2018. PMID: 30392756
-
[Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)].Rinsho Byori. 2009 Mar;57(3):242-51. Rinsho Byori. 2009. PMID: 19363995 Review. Japanese.
-
An overview of Notch3 function in vascular smooth muscle cells.Prog Biophys Mol Biol. 2008 Jan-Apr;96(1-3):499-509. doi: 10.1016/j.pbiomolbio.2007.07.006. Epub 2007 Jul 29. Prog Biophys Mol Biol. 2008. PMID: 17854869 Review.
Cited by
-
Vascular smooth muscle cell dysfunction in neurodegeneration.Front Neurosci. 2022 Nov 10;16:1010164. doi: 10.3389/fnins.2022.1010164. eCollection 2022. Front Neurosci. 2022. PMID: 36440263 Free PMC article. Review.
-
A novel cysteine-sparing G73A mutation of NOTCH3 in a Chinese CADASIL family.Neurogenetics. 2020 Jan;21(1):39-49. doi: 10.1007/s10048-019-00592-3. Epub 2019 Nov 13. Neurogenetics. 2020. PMID: 31720972
-
Metformin decreases hyaluronan synthesis by vascular smooth muscle cells.J Investig Med. 2020 Feb;68(2):383-391. doi: 10.1136/jim-2019-001156. Epub 2019 Oct 30. J Investig Med. 2020. PMID: 31672719 Free PMC article.
-
Pathophysiological Mechanisms and Potential Therapeutic Targets in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL).Front Pharmacol. 2020 Mar 13;11:321. doi: 10.3389/fphar.2020.00321. eCollection 2020. Front Pharmacol. 2020. PMID: 32231578 Free PMC article. Review.
-
ER stress and Rho kinase activation underlie the vasculopathy of CADASIL.JCI Insight. 2019 Dec 5;4(23):e131344. doi: 10.1172/jci.insight.131344. JCI Insight. 2019. PMID: 31647781 Free PMC article.
References
-
- Joutel A, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511–5. - PubMed
-
- Dichgans M, Ludwig H, Muller-Hocker J, Messerschmidt A, Gasser T. Small inframe deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur J Hum Genet. 2000;8:280–5. - PubMed
-
- Brou C, et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell. 2000;5:207–16. - PubMed
-
- Mumm JS, et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell. 2000;5:197–206. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous